Brief: Shandong Weigao Group Medical Polymer Co gets Approval For Participation In H Share Full Circulation Pilot Project
10/07/2018 13:03
July 10 (Reuters) - Shandong Weigao Group Medical Polymer Co
Ltd 1066.HK :
* RECEIVED APPROVAL LETTER FROM CSRC IN RESPECT OF
PARTICIPATION
IN THE H SHARE FULL CIRCULATION PILOT PROJECT
* CO IS ALLOWED TO CONVERT AND LIST UP TO 2.64 BILLION
UNLISTED
SHARES OR DOMESTIC SHARES INTO H SHARES
Source text for Eikon: ID:nHKS2mZG4s
Further company coverage: 1066.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shandong Weigao Medical Polymer
See all newsChina's Weigao H1 profit falls 23% as price drops, competition hit margins
Brief: Shandong Weigao Group Medical Polymer H1 Net Income Attributable RMB 890.4 Mln
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 11.4 Million H Shares From 15 May 2026 To June 5
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 3.6 Million H Shares
Brief: Shandong Weigao Group Medical Polymer Says Unit To Establish Fund Of KRW52.965 Billion